14
Views
23
CrossRef citations to date
0
Altmetric
Original Article

Autoantibodies to Poly(ADP-Ribose)Polymerase in Autoimmune Diseases

, , , , , , , & show all
Pages 203-209 | Received 09 Oct 1989, Accepted 07 Dec 1989, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hiroki Kawabata, Minoru Satoh, Tomoko Hasegawa, Shin Tanaka, Kanako Hara & Kazuhiro Yatera. (2023) Clinical significance of serum autoantibodies in patients with sarcoidosis. Immunopharmacology and Immunotoxicology 45:4, pages 479-484.
Read now
B. Cerboni, A. Di Stefano, V. Micheli, G. Morozzi, G. Pompucci & S. Sestini. (2010) PARP Activity and NAD Concentration in PMC from Patients Affected by Systemic Sclerosis and Lupus Erythematosus. Nucleosides, Nucleotides & Nucleic Acids 29:4-6, pages 471-475.
Read now
Maria Rosaria Faraone-Mennella, Raffaele Scarpa, Anna Petrella, Francesco Manguso, Rosario Peluso & Benedetta Farina. (2009) Detecting clinical activity in systemic lupus erythematosus with an archaeal poly(ADP-ribose) polymerase-like thermozyme: a pivotal study. Biomarkers 14:6, pages 381-387.
Read now

Articles from other publishers (20)

Luca Palazzo, Petra Mikolčević, Andreja Mikoč & Ivan Ahel. (2019) ADP-ribosylation signalling and human disease. Open Biology 9:4.
Crossref
Pamlea N. Brady, Anupam Goel & Margaret A. Johnson. (2019) Poly(ADP-Ribose) Polymerases in Host-Pathogen Interactions, Inflammation, and Immunity. Microbiology and Molecular Biology Reviews 83:1.
Crossref
A. Dubaniewicz, L. Kalinowski, M. Dudziak, A. Kalinowska & M. Singh. 2015. Noncommunicable Diseases. Noncommunicable Diseases 41 49 .
Nicola J. Curtin & Csaba Szabo. (2013) Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond. Molecular Aspects of Medicine 34:6, pages 1217-1256.
Crossref
Rafael Alvarez-Gonzalez. 2011. Post-Translational Modifications in Health and Disease. Post-Translational Modifications in Health and Disease 411 424 .
Barbara Cerboni, Gabriella Morozzi, Mauro Galeazzi, Francesca Bellisai, Vanna Micheli, Giuseppe Pompucci & Silvia Sestini. (2009) Poly(ADP-ribose) polymerase activity in systemic lupus erythematosus and systemic sclerosis. Human Immunology 70:7, pages 487-491.
Crossref
Pal Pacher & Csaba Szabo. (2008) Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease. The American Journal of Pathology 173:1, pages 2-13.
Crossref
John G. Routsias & Athanasios G. Tzioufas. (2007) Sjögren’s Syndrome—Study of Autoantigens and Autoantibodies. Clinical Reviews in Allergy & Immunology 32:3, pages 238-251.
Crossref
I. Böhm. (2006) Das Apoptose-Markerenzym Poly-(ADP-Ribose-)Polymerase (PARP) beim systemischen Lupus erythematodesThe apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus. Zeitschrift für Rheumatologie 65:6, pages 541-544.
Crossref
Csaba Szabó. (2006) Poly(ADP-ribose) polymerase activation by reactive nitrogen species—Relevance for the pathogenesis of inflammation. Nitric Oxide 14:2, pages 169-179.
Crossref
Csaba Szabó. 2006. Poly(ADP-Ribosyl)ation. Poly(ADP-Ribosyl)ation 184 202 .
Anna Dubaniewicz, Sarra E Jamieson, M Dubaniewicz-Wybieralska, Michaela Fakiola, E Nancy Miller & Jenefer M Blackwell. (2005) Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. European Journal of Human Genetics 13:7, pages 829-834.
Crossref
Yaniv Sherer, Alexander Gorstein, Marvin J. Fritzler & Yehuda Shoenfeld. (2004) Autoantibody explosion in systemic lupus erythematosus: More than 100 different antibodies found in SLE patients. Seminars in Arthritis and Rheumatism 34:2, pages 501-537.
Crossref
Dooil Jeoung, Yoon Lim, Eun Bong Lee, Seongeun Lee, Hae-Yeong Kim, Hansoo Lee & Yeong Wook Song. (2004) Identification of autoantibody against poly (ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus. Journal of Autoimmunity 22:1, pages 87-94.
Crossref
Yoon Lim, Dae-Yeon Lee, Seongeun Lee, Sae-Young Park, Jongwan Kim, Bomsoo Cho, Hosoon Lee, Hae-Yeong Kim, Eunbong Lee, Yeong Wook Song & Doo-Il Jeoung. (2002) Identification of autoantibodies associated with systemic lupus erythematosus. Biochemical and Biophysical Research Communications 295:1, pages 119-124.
Crossref
Cleo Robinson, Marinella Callow, Sandra Stevenson, Bruce WS Robinson & Richard A Lake. (2001) Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis. Respiratory Research 2:2.
Crossref
O. Delrieu, M. Michel, C. Franc�s, O. Meyer, C. Michel, F. Wittke, I. Crassard, J. F. Bach, E. Tournier-Lasserve & J. C. Piette. (1999) Poly(ADP-ribose) polymerase alleles in French Caucasians are associated neither with lupus nor with primary antiphospholipid syndrome. Arthritis & Rheumatism 42:10, pages 2194-2197.
Crossref
H-Y. Chen, RM Pertusi, JB Kirkland, BR Rubin & EL Jacobson. (2016) Biochemical characterization of ADP-ribose polymer metabolism in SLE. Lupus 5:1, pages 14-21.
Crossref
A. I. SCOVASSI, C. NEGRI, M. NEGRONI, V. DAL, R. M. BORZÌ, R. MELICONI, A. FACCHINI, C. M. MONTECUCCO & G. C. B. ASTALDI RICOTTIM. (2006) Detection of Circulating Autoantibodies to Poly(ADP‐Ribose)Polymerase in Autoimmune Diseasesa. Annals of the New York Academy of Sciences 663:1, pages 508-509.
Crossref
Jozefa Wesierska-Gadek, Edward Penner, Peter Kier, Eva Hitchman & Georg Sauermann. 1992. ADP-Ribosylation Reactions. ADP-Ribosylation Reactions 251 255 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.